| [1] |
Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.
Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer
[J]. Journal of International Oncology, 2024, 51(5): 286-291.
|
| [2] |
Gong Yan, Chen Honglei.
Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer
[J]. Journal of International Oncology, 2024, 51(3): 186-190.
|
| [3] |
Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying.
Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer
[J]. Journal of International Oncology, 2023, 50(8): 475-483.
|
| [4] |
An Rong, Liu Meihua, Wang Peichen, Wang Xiaohui.
Research progress of Nrf2 in ovarian cancer
[J]. Journal of International Oncology, 2023, 50(8): 493-497.
|
| [5] |
Li Chenxi, Zhao Hongwei.
Prognosis and influencing factors of platinum sensitive recurrent ovarian cancer treated by secondary cytoreduction surgery in patients with unsatisfactory primary cytoreduction surgery
[J]. Journal of International Oncology, 2023, 50(6): 342-347.
|
| [6] |
Lyu Lu, Sun Pengfei.
Gut flora and cervical cancer
[J]. Journal of International Oncology, 2023, 50(6): 373-376.
|
| [7] |
Fan Mengsi, Lu Yaping, Yan Li.
Analysis of clinicopathologic features of false negative sentinel lymph nodes in patients with endometrial cancer
[J]. Journal of International Oncology, 2023, 50(5): 274-279.
|
| [8] |
Yang Lirong, Wang Yufeng.
Construction of machine learning models for predicting the risk of postoperative distant metastasis recurrence in serous ovarian cancer
[J]. Journal of International Oncology, 2023, 50(4): 220-226.
|
| [9] |
Ma Xueyan, Lu Lili, Sun Pengfei.
Advances in the immune microenvironment in cervical cancer
[J]. Journal of International Oncology, 2023, 50(1): 47-50.
|
| [10] |
Zhang Lu, Zhou Juying, Ma Chenying, Lin Zhou.
Advances in immunotherapy for recurrent and metastatic cervical cancer
[J]. Journal of International Oncology, 2022, 49(9): 517-520.
|
| [11] |
Shi Yingxia, Hu Lijun, Yu Jingping.
Application of immune checkpoint inhibitors in the treatment of recurrent or metastatic cervical cancer
[J]. Journal of International Oncology, 2022, 49(9): 568-571.
|
| [12] |
Peng Chen, Xie Yintong, Zhang Xin, Xie Peng.
Research progress of maintenance therapy for cervical cancer
[J]. Journal of International Oncology, 2022, 49(7): 430-435.
|
| [13] |
Yuan Chenyang, Zhou Juying.
Research progress on prognostic factors of cervical cancer
[J]. Journal of International Oncology, 2022, 49(5): 307-313.
|
| [14] |
Wang Yue, Wu Qiong, Xu Yuan, Gong Wei, Xu Xiaoting.
Screening and treatment progression of elderly cervical cancer
[J]. Journal of International Oncology, 2022, 49(12): 754-758.
|
| [15] |
Xu Qiuyue, Ma Xianmei, Yue Qi.
Immunotherapy for endometrial carcinoma based on molecular typing
[J]. Journal of International Oncology, 2022, 49(11): 700-704.
|
